Skip to main content
Back to News

News From Around the System

3D Printed Implant Promotes Nerve Cell Growth to Treat Spinal Cord Injury

UC San Diego Health — May 12, 2022

For the first time, researchers at University of California San Diego have used rapid 3D printing technologies to create a spinal cord, then successfully implanted that scaffolding, loaded with neural stem cells, into sites of severe spinal cord injury in rats.

$2.1 Million Gift Launches Comprehensive Breast Cancer Database

UC San Diego Health — May 12, 2022

Philanthropists Richard and Carol Dean Hertzberg have committed $2.1 million to develop and maintain the Dean-Hertzberg Breast Cancer Database System Initiative at UC San Diego Health Moores Cancer Center to support the work of Anne Wallace, MD and her collaborators at Moores Cancer Center.

2019: A Space Organoid

UC San Diego Health — May 12, 2022

UC San Diego will launch a payload of stem cell-derived human brain organoids to the International Space Station. Researchers will document how these “mini brains” organize into the beginnings of a functional brain with implications for the future of human life in space.

Genetic Changes in Head and Neck Cancer, Immunotherapy Resistance Identified

UC San Diego Health — May 12, 2022

A multi-institutional team of researchers, led by UC San Diego School of Medicine and Moores Cancer Center, has identified both the genetic abnormalities that drive pre-cancer cells into becoming an invasive type of head and neck cancer and patients who are least likely to respond to immunotherapy.

Five UC San Diego Experts Elected AAAS Fellows in 2020

UC San Diego Health — May 12, 2022

American Association for the Advancement of Science honors the contributions of UC San Diego leaders in astrophysics, research advocacy, organic chemistry, psychiatry and geophysics.

First-in-Human Clinical Trial to Assess Gene Therapy for Alzheimer’s Disease

UC San Diego Health — May 12, 2022

UC San Diego researchers have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons with Alzheimer’s disease or Mild Cognitive Impairment, a condition that often precedes full-blown dementia.

Health Media Contacts

Find the best contact for health-related media inquiries.

View All Media Contacts